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CHAPTER 1 
INTRODUCTION 
 
Endophthalmitis is an inflammation of the internal layers of the eye 
resulting from intraocular colonization of infectious agents 
manifesting with an exudation into the vitreous cavity. 
Endophthalmitis is otherwise called as vitreous abscess. 
Endophthalmitis is an entity that can rapidly destroy vision and is a 
true emergency. 
Colonization of organisms inside the eye can happen either following 
breech in the ocular coats or by dissemination through the systemic 
blood stream. But, entry of an infectious agent into vitreous cavity is a 
pre requisite for endophthalmitis to occur. The commonest causes of 
major breach in the integrity of ocular coats are intraocular surgery 
and penetrating trauma. Although the incidence of endophthalmitis 
have sharply declined over the past decades, it is a surgeon’s 
nightmare. Even today, in the era of all latest facilities and 
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technologies and despite the best available therapeutic efforts, the 
prognosis remains extremely variable. 
Infectious endophthalmitis is the inflammation associated with 
infective process. It may be exogenous in origin following intraocular 
surgery or trauma. Or it may be endogenous when infectious 
organism reach the eye through haematogenous dissemination. Non-
infectious endophthalmitis may follow inflammatory response to 
retained lens material, intraocular foreign body resulting in sterile 
endophthalmitis. 
ANATOMY OF THE UVEAL TRACT 
Uvea is the Latin word for grape. The term uveal tract means the 
vascular middle layer of the eye consisting of iris anteriorly ciliary 
body in the middle and the choroid posteriorly. Embryologically, 
uveal tract is derived from the neuroectoderm, neural crest cells and 
vascular channels.  
Ciliary arteries which originate from the ophthalmic artery supply 
blood to the whole vascular tunic. Iris and ciliary body are supplied 
by the anterior and long posterior ciliary arteries via the major arterial 
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circle. Choroid is mainly supplied by the short posterior ciliary 
arteries. Venous drainage of the uvea is provided by the vortex veins 
and by the scleral and episcleral venous system. 
The structures of the uveal tract share a common blood supply so 
together involved in the inflammatory processes. Because of its 
extreme vascularity, uveal tract is an ideal site for dissemination 
occurring in endogenous endophthalmitis. 
VITREOUS HUMOUR 
Vitreous humour is an inert, colourless, hydrophilic gel serves the 
optical functions and acts as a supporting structure for the eyeball. It’s 
about 4cc and forms two thirds of the volume of the entire globe. It 
may be divided into 3 parts namely hyaloid membrane, cortical 
vitreous and medullary vitreous. Vitreous body is composed of water 
(99%) collagen, hyaluronic acid, sugars such as glucose, galactose, 
mannose, fructose and soluble proteins. Once the organism enters the 
vitreous cavity through a breach in the ocular coats, the vitreous 
serves as an excellent culture medium that the organisms can 
proliferate within. 
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                 CLASSIFICATION OF ENDOPHTHALMITIS 
 
                             INFECTIVE                                                                                NON-INFECTIVE 
 (Sterile endophthalmitis) 
EXOGENOUS                          ENDOGENOUS                                                    
                                                     Bacterial 
                                                     Fungal                                                                            
1. Post-operative 
(Cataract, Antiglaucoma, 
Bleb related, Keratoplasty, 
Secondary IOL implantation, 
Internal RD, PPV, 
External RD [infected buckle])  
 
2. Post traumatic  
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POSTSURGICAL ENDOPHTHALMITIS 
FULMINANT 
(<4days) 
ACUTE (5-7 days) CHRONIC (>4weeks) 
Gram negative bacteria 
(Pseudomonas) 
Staph. Epidermidis Delayed entry (Bleb) 
Streptococci 
Coagulase negative 
cocci  
Delayed onset 
(P.acnes, Fungi) 
Staph. Aureus 
  
 
NONINFECTIOUS CAUSES OF CHRONIC POSTOPERATIVE 
INTRAOCULAR INFLAMMATION 
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 Lens induced uveitis (phacoantigenic uveitis) 
Retained cortical material 
Retained intravitreal lens fragments 
 Intraocular lens related uveitis 
Iris chafing/IOL malposition 
UGH (Uveitis-Glaucoma-Hyphema) syndrome 
IOL material related. 
 Other causes 
Masquerade syndromes (intra ocular lymphoma) 
Sympathetic ophthalmia 
Uveitis of other causes unrelated to surgery 
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HISTORICAL REVIEW 
Incidence of different types of endophthalmitis 
POSTOPERATIVE ENDOPHTHALMITIS 
Postoperative endophthalmitis is a catastrophic complication of 
intraocular surgery. Its reported incidence in the present era has 
considerably decreased because of the strict aseptic precautions used 
and use of broad spectrum antibiotics. Christy et al conducted the first 
study on postop endophthalmitis and the incidence was 0.5%. Now 
the incidence is about 0.1% to 0.3%. 
Kattan et al conducted study in 30,002 cases and reported the 
incidence pattern of different forms of surgeries as 
 ECCE -0.082% 
 Secondary IOL implantation- 0.30% 
 Penetrating keratoplasty-0.11% 
 Filtering surgery for glaucoma-0.061% 
 PPV-0.051% 
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The study reported an increased incidence of endophthalmitis in 
diabetics. 90-95% of culture from all postsurgical endophthalmitis 
revealed gram positive organisms. 
PENETRATING KERATOPLASTY ENDOPHTHALMITIS  
Endophthalmitis can present in the immediate postoperative period 
usually within 72 hours of surgery. Contaminated donor tissue or 
corneal storage media may be the source of the infection. Prolonged 
storage of corneal tissue for more than 5 days may also be a risk 
factor for endophthalmitis. 
FILTERING BLEB ASSOSIATED ENDOPHTHALMITIS 
The incidence reported was 0.2 to 1%. Wolner and group reported 
that incidence of endophthalmitis increased with usage of 
antimetabolites such as Mitomycin C and 5-Flurouracil. 
POST TRAUMATIC ENDOPHTHALMITIS 
The correct incidence was difficult to confirm as most of the cases 
were poorly reported. Barr and associates found out that the incidence 
was about 3.3%. The incidence increased up to 7% in case of retained 
intra ocular foreign body. 
8 
 
 
 
PHACOEMULSIFICATION 
Use of phacoemulsification increases pressure within the eye forcing 
bacteria backwards into the vitreous, where early multiplication gives 
rise to the anterior vitritis characteristically seen behind the posterior 
capsule. The incidence of endophthalmitis with phacoemulsification 
and clear cornea incisions is between 0.3 to 0.5 and 0.015 per cent. 
(ESCRS) 
 
DEFINITION OF TERMS 
 Culture positive: Any organism that has grown in more than one 
culture media. 
 Dry tap: in absence of aspiration of fluid from vitreous cavity 
using a 26 gauge needle. 
 Good visual recovery: Any patient whose vision after treatment 
improved to more than 6/60. 
 Satisfactory: visual recovery between 2/60 and 6/60 
 Poor: visual recovery < 2/60 
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GRADING OF MEDIA BY INDIRECT OPHTHALMOSCOPY 
GRADE 1- Media clarity of 6/12 or more in viewing retina 
GRADE 2- Media clarity <6/12 .Second order retinal vessels visible 
GRADE 3- First order main retinal vessels seen 
GRADE 4- Vessels not seen. Red reflex present. 
GRADE5- Absence of red reflex  
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ACUTE ONSET POST OPERATIVE ENDOPHTHALMITIS 
 
 
 
POST TRAUMATIC ENDOPHTHALMITIS 
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DELAYED ONSET P.ACNES ENDOPHTHALMITIS (WHITE 
PLAQUES SEEN) 
 
 
 
CHRONIC POST OP ENDOPHTHALMITIS 
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CANDIDA ENDOPHTHALMITIS (FLUFFY YELLOW BALLS) 
 
 
 
ENDOPHTHALMITIS SECONDARY TO IOFB 
  
 
 
 
 
 
 
 
Review of 
Literature 
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CHAPTER 2 
 
RISK FACTORS FOR ENDOPHTHALMITIS 
POSTOPERATIVE ENDOPHTHALMITIS 
Acute endophthalmitis is one of the most devastating complications of 
cataract surgery. Several risk factors are associated with postop 
endophthalmitis but the level of evidence and the strength of 
association is varied. Typically, postoperative endophthalmitis is 
caused by the perioperative introduction of microbial organisms into 
the eye either from the patient's normal conjunctival and skin flora or 
from contaminated instruments. Once organisms gain access to the 
vitreous cavity, overwhelming inflammation is likely to occur. Most 
of the cases occur within 6 weeks of postoperative period. 
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RISK FACTORS 
Pre-operative  
Presence of any active infection  
 Blepharitis 
 Meibomianitis  
 Dacryocystitis  
 Conjunctivitis  
 Peripheral ulcerative keratitis. 
 Secondary to dry eyes. 
Intra operative 
 Improper theatre sterilization. 
 Improper surgical scrubbing of the doctor. 
 Inadequate draping with povidone iodine 
 Posterior capsule rupture 
 Vitreous loss 
 Prolonged procedure time 
 Combined procedure (with vitrectomy)  
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 Clear corneal sutureless incision 
 Temporal incision 
 Sutureless sclerotomies 
 Retained lens matter 
 Usage of contaminated instruments or irrigating fluids 
Post-operative 
 Wound leak or dehiscence  
 Delaying postoperative topical antibiotics the day after surgery 
 Vitreous incarceration in the wound 
 Suture removal 
 
ENDOGENOUS ENDOPHTHALMITIS 
 Uncontrolled diabetes mellitus 
 Immunosuppressive conditions 
 Indwelling catheters 
 Hemodialysis 
 Immunosuppression  for autoimmune disease and transplant 
 Bone marrow suppression 
17 
 
 
 
 Hepatic disease 
 Postpartum 
 Underlying systemic autoimmune disease 
 
POST TRAUMATIC ENDOPHTHALMITIS 
 Retained IOFB. 
 Larger full thickness penetrating wound. 
 Absence of use of prophylactic antibiotics in the post traumatic 
period. 
 Lens disruption in penetrating injuries. 
 Wound dehiscence. 
 Protruded sutures.  
 Delayed primary repair of open globe injuries. 
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BASELINE RISK FACTORS FOR DECREASED VISUAL 
ACUITY OUTCOME 
 
 Older age group 
 Corneal infiltrate 
 Corneal ring ulcer 
 Posterior capsule not intact 
 Intraocular pressure <5mm Hg or > 25mm Hg 
 Afferent pupillary defect 
 Rubeosis iridis 
 Absent red reflex 
 Visual acuity of light perception is the most important risk 
factor with 2 fold increased risk of poor visual outcome 
compared with those with better visual acuity at the time of 
presentation. 
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MICROBIAL SPECTRUM IN ENDOPHTHALMITIS 
 
Gram positive organisms are responsible for almost 80-90% of all 
post-surgical endophthalmitis. Gram negative infections are up to 7% 
but are highly virulent and may need early vitrectomy. Most of the 
cases are caused by the organisms that normally inhabit the 
conjunctival sac. Staph. Epidermidis has been isolated from 
conjunctival sac in 69%. 
 
Post-operative endophthalmitis:  
Coagulase-negative staphylococci (Staph. Epidermidis) is the most 
common. (50-70%) Staphylococcus aureus (15%), Streptococcus 
pneumoniae, alpha-haemolytic streptococci including S. mitis and S. 
salivarius(10%), Gram-negative bacteria including Ps. aeruginosa 
(occurs rarely) Fungi (Candida, Aspergillus, Fusarium) (8%) are the 
other causative organisms in post-operative endophthalmitis. 
Delayed post-operative saccular or capsule bag endophthalmitis: 
Propionibacterium acnes, corynebacteria including C. macginleyi and 
fungi. 
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Bleb related endophthalmitis: 
Coagulase negative staphylococci (67%) 
Post traumatic endophthalmitis: 
Coagulase negative Staph. Epidermidis 
Bacillus 
Streptococci 
Fungi 
Corynebacterium. 
Endogenous endophthalmitis: 
Staph. Aureus 
Gram positive streptococci (endocarditis) 
Bacillus, E.coli, Klebsiella 
Neisseria meningitides 
Fungi (Candida, Fusarium, Aspergillus) 
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HOST DEFENCE MECHANISMS &IMMUNE PRIVILEGE OF 
EYE 
 
There are several defence mechanisms which protect the ocular 
surfaces. 
EYELIDS AND LASHES: acts as a mechanical barrier protecting the 
ocular surface from pathogens and allergens. 
 
TEAR FILM: The outermost lipid layer act as a surfactant enhancing 
the microbial trap. The middle aqueous layer undergoes continuous 
turn over with the pumping action of the blink help in flushing out the 
microbes. The innermost mucous blanket prevents the pathogen 
adherence to the surface. 
1. Lactoferrin-iron binding protein enhances NKcell activity and 
compliment activation. 
2. Lysozyme -cleaves the polysaccharide backbone of the bacterial 
cell wall and chitin in the fungal cell wall. 
3. Beta lysin- attacks bacterial membranes. 
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4. Immunoglobulins- have a role in opsonisation of pathogens, 
blocks pathogen binding to ocular surface and neutralization of 
toxins. IgA from plasma cells of lacrimal gland prevent 
microbial adherence especially pseudomonas and 
acanthoemoeba. 
5. Complement- promotes cell lysis. 
6. Fibronectin- enhances phagocytosis. 
7. Defensins and Phospholipase A2 also prevent pathogens. 
OCULAR MUCOSAL IMMUNITY - provided by the MALT 
(Mucosa associated Lymphoid Tissue of conjunctiva prevents 
microbial invasion. 
EPITHELIUM - the apical epithelial cells with the tight junctions 
made by desmosomes and macula occludentes prevents microbial 
penetrance. 
BLOOD OCULAR BARRIER - the inner blood retinal barrier is 
composed of tight junctions of retinal capillary endothelial cells. The 
outer barrier consists of tight junctions between RPE cells. The blood 
aqueous barrier is formed by the tight junctions between the cells of 
inner non pigmented epithelium of ciliary body and non-fenestrated 
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endothelium of iris capillaries. These prevent the penetration of large 
molecules especially bacterial proteins. 
ANTERIOR OR POSTERIOR CHAMBER-ASSOCIATED 
IMMUNE DEVIATION (ACAID OR POCAID) - Inoculation of 
antigens into the anterior chamber or vitreous elicits a deviant 
systemic immune response. There will be transient depression of cell-
mediated immunity, particularly delayed-type hypersensitivity while 
the humoral response mediated by B cells that produce complement 
fixing antibodies is preserved.  Delayed hypersensitivity is an 
effective means of killing pathogens, but potentially destructive to 
surrounding tissues because of the intense lymphokine-induced 
inflammation. Suppression of this by ACAID may preserve vision 
while permitting some degree of local immunity. This phenomenon is 
known as anterior chamber-associated immune deviation which is a 
dangerous compromise between the eye and the immune system. This 
is an immune privilege for the eye which can be compromised in PC 
rent with vitreous loss can lead on to endophthalmitis. 
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CLINICAL FEATURES 
 
ACUTE POST OP ENDOPHTHALMITIS 
 
Commences between the first post-operative day and approximately 
two weeks after the operation. 
SYMPTOMS 
Decreased visual acuity (90%) 
Increasing ocular pain (85%) 
Red eye (60%) 
Ocular discharge 
Lid oedema 
SIGNS 
Conjunctival chemosis                                    Retrolenticular cells 
Corneal edema or infiltration                          Corneal abscess  
Hypopyon                                                       Air bubble in eye 
Pupillary membrane                                        Retinal periphlebitis 
Absent or poor red glow                                 Fibrin in AC  
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CHRONIC LATE ENDOPHTHALMITIS 
 
Commences usually after two weeks but may take many months to 
appear. It is usually caused by Propionibacterium acnes, Staph. 
Epidermidis and fungi. In P.acnes endophthalmitis, whitish plaques 
are found in the capsular sac (60-80%). There may be associated 
features like granulomatous KPs, vitritis and retained lens material 
sequestrated within the capsular bag. 
P.acne endophthalmitis may usually follow a YAG capsulotomy. 
Hypopyon in (67%) and keratitis (26%) are found in fungal 
endophthalmitis. Pyramid-shaped hypopyon is typical of a mycotic 
cause.  
DEFENITIONS OF DIFFERENT CATEGORIES OF POSTOP 
ENDOPHTHALMITIS
7 
Acute postop endophthalmitis is defined as intraocular inflammation 
secondary to an infectious cause characterised by an explosive onset 
and occurring in the immediate postoperative period following ocular 
surgery (<7days).  
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Delayed onset endophthalmitis is defined as an intraocular 
inflammation secondary to an infectious cause characterised by an 
explosive onset, but occurring upto 4 weeks after an ocular surgery. 
Chronic postop endophthalmitis is defined as intraocular 
inflammation secondary to infectious cause characterised by indolent 
inflammation occurring any time following an ocular surgery. 
 
POST TRAUMATIC ENDOPHTHALMITIS 
 
Post traumatic endophthalmitis should be suspected when a patient 
presents with increasing pain, proptosis, chemosis, corneal infiltrates, 
hypopyon after a penetrating injury. Larger the wound, retained 
foreign bodies, injury with contaminated objects, injury with 
vegetable matter increases the risk.  
 
ENDOGENOUS ENDOPHTHALMITIS 
 
Endogenous endophthalmitis presents with sudden onset pain, 
decreased vision, red eye or hypopyon in an immunocompromised 
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patients. May be associated white fluffy inner choroidal lesions 
breaking into the vitreous with budding (Candida). There is increased 
vitritis and perivascular inflammatory deposits. 
Endogenous endophthalmitis occur as a result of haematogenous 
spread of infectious organisms to the eye which crosses the blood 
retinal barrier. It is otherwise called as metastatic endophthalmitis. 
Causative organism can be bacterial or fungal. Fungal endogenous 
endophthalmitis is most common. Most common fungal organisms 
responsible for this entity are Candida and Aspergillus. Rarely 
Histoplasma, Coccidiomycosis, Fusarium, Sporothrix, Mucormycosis 
have been isolated. Bacterial causative organisms may be 
Streptococci (32%) E.coli (18%) Klebsiella, Bacillus and Serratia.
26 
Greenwald proposed a classification for endogenous endophthalmitis 
as the clinical presentation can be extremely variable. 
 
ENDOGENOUS ENDOPHTHALMITIS 
FOCAL                          DIFFUSE                   PANOPHTHALMITIS 
ANTERIOR                   ANTERIOR 
POSTERIOR                 POSTERIOR 
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Focal endophthalmitis: may be associated with inflammatory nodules 
on iris, retina and choroid. There will be mild inflammation of the 
anterior chamber with moderate vitreous haze. These cases usually 
have good prognosis.  
Diffuse anterior endophthalmitis: associated with severe anterior 
chamber inflammation with conjunctival chemosis, fibrin clots in 
anterior chamber and significant hypopyon. IOP is elevated. 
Prognosis is excellent with early and vigorous treatment. 
Diffuse posterior endophthalmitis: associated with dense vitritis. 
Progressive necrosis of the retina is characteristic. Poor visual 
prognosis can be explained by retinal ischemia primary by 
inflammatory necrosis or secondary due to septic emboli causing 
central retinal artery occlusion. 
Endogenous endophthalmitis usually occurs in immunocompromised 
individuals. The possibility of endogenous endophthalmitis should be  
considered in any patient who manifests a pronounced anterior 
reaction that is refractory to steroid treatment. 
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PROGNOSIS 
Prognosis of endophthalmitis is extremely variable. Mainly depends 
upon 
 Depends on the virulence and the number of the invading 
organisms. Highly virulent organisms and high bacterial load 
are associated with worse prognosis. 
 Time duration between the onset and initiation of therapy. 
Earlier the intervention, better will be the prognosis. 
 Complications such as retinal detachment choroidal detachment 
are associated with worse prognosis. 
 Presence of intra ocular foreign body is associated with bad 
prognosis. 
 Denser the amount of vitreous inflammation, worser the 
prognosis. 
 Postoperative endophthalmitis has a better prognosis than post 
traumatic endophthalmitis.
11
 
 Older age group have bad prognosis. 
 Association of systemic diseases such as Diabetes have bad 
prognosis.
2
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 Presence of Relative Afferent Pupillary Defect have bad 
prognosis.
2
 
 Presence of corneal infiltrate or ring ulcer is associated with bad 
prognosis. 
The axiom “if it isn’t worse, its better” may apply in the case of 
endophthalmitis as the media clarity and visual acuity may not 
improve initially.  
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DIFFERENTIAL DIAGNOSIS OF INFECTIVE 
ENDOPHTHALMITIS 
2, 8
 
 Toxic anterior segment syndrome (TASS) 
 Phacolytic glaucoma 
 Severe sterile postoperative inflammation 
 Lens induced inflammation  
 Inadvertent toxic substance introduced into eye 
 Drug induced 
Rifabutin (frequently associated with hypopyon) 
Metipranolol 
 Neoplastic infiltration such as in leukaemia 
 Masquerade syndromes 
 Ruptured cysticercosis 
 Viral retinitis as in the form of acute retinal necrosis, 
progressive outer retinal necrosis or CMV retinitis. 
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TOXIC ANTERIOR SEGMENT SYNDROME (TASS) 
 
TASS refers to sterile postoperative inflammatory response to non-
infectious agents entering the anterior chamber
8
. This entity manifests 
early within 48 hours. A variant of TASS is also described called as 
toxic endothelial cell destruction (TECD) syndrome. It is 
characterised by diffuse limbus to limbus corneal oedema and anterior 
segment inflammation. TASS occurs as a result of the inadvertent 
entry of toxic substances into the anterior chamber leading onto 
cellular necrosis. Corneal endothelium is the most damaged structure 
in TASS because of its inability to regenerate. Toxic agents induce 
the acute breakdown of endothelial junctions with loss of the blood 
aqueous barrier function 
Causes: 
Extra ocular substances entering AC such as topical antiseptic 
agents, talc from surgical gloves, topical anaesthetic agents, 
preservatives in the drug as Benzalkonium chloride, Mitomycin-C, 
Intraocular lenses specifically phakic intraocular lenses and 
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contaminated irrigating solutions such as balanced salt solution 
contaminated with bacterial endotoxin 
 
Features TASS 
Infectious 
Endophthalmitis 
Onset Rapid onset ; 12- 24hours 2-7 days usually 
Pain Mild or no pain Usually severe 
Corneal 
edema 
 Diffuse Limbus to limbus No specific pattern 
Anterior 
chamber 
reaction 
Moderate-to-severe anterior 
chamber reaction with 
increased white blood cells 
and fibrin. Hypopyon may 
be present. 
Moderate-to-severe 
anterior chamber reaction. 
Hypopyon often present 
(75% ) 
Vitritis Very rare Always present 
Visual 
acuity 
Decreased Decreased 
Response 
to steroids 
Dramatic improvement 
No improvement only 
with steroids 
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LABORATORY DIAGNOSIS 
 
A medical emergency exists as soon as the clinical diagnosis is made 
of acute bacterial endophthalmitis. It’s important to identify the 
causative organism and treat accordingly. 
 
COLLECTION OF SPECIMEN 
The most important samples to culture are aspirates from the aqueous 
and vitreous cavity. The possibility of isolating an organism from 
vitreous sample is about 70% and aqueous sample is about 40%. The 
other specimens that can be used are explanted IOL, remnants of the 
lens and capsule and rarely eviscerated globe contents. Vitrectomy 
provides the maximum amount of material for diagnosis. 
If an aspirate obtained can be reached immediately then the 
specimens are best sent to the laboratory with the original syringe 
with a cap on the needle. If processing is delayed the sample should 
be fixed with equal volume of 95%ethyl alcohol. Or preferably the 
smear can be made and inoculate the specimen into an appropriate 
culture media.  
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AQUEOUS TAP 
 Under topical anaesthesia, 5% povidone iodine is instilled and 
washed. 
 Speculum is inserted. 
 Using a 27G tuberculin syringe (preferably) or 25G needle 0.1-
0.2 ml fluid is aspirated via limbal paracentesis.  
 The syringe is capped and labelled. 
 
VITREOUS TAP 
Pars plana aspiration: 
 Under topical anaesthesia, 5% povidone iodine is instilled and 
washed. 
 Speculum is inserted. 
 Using a 26G needle the site of insertion is marked from the 
limbus.3mm(aphakic) 3.5mm (pseudophakic) 4mm (phakic) 
 0.2ml of fluid is aspirated. In case of fungal endophthalmitis 
usually dry tap is the result. Effort should be made to obtain the 
fluffy mass. 
 The syringe is capped and labelled. 
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IN THE ABSENCE OF POSTERIOR CHAMBER IOL AND 
INTACT POSTERIOR LENS CAPSULE 
 Widen the initial keratotomy from the anterior chamber tap. 
 Insert a 22G needle attached to 3ml syringe, 3.5mm posterior 
to the limbus into the mid vitreous cavity 
 Aspirate gently to yield 0.2 to 0.3 ml of liquid vitreous 
 If the yield is poor consider vitrectomy. 
 
Vitreous biopsy: 
The safest method to obtain vitreous sample is vitreous biopsy using a 
vitreous cutter. Prevents the vitreous traction by cutting rather than 
pulling it. There are 2 methods to obtain the samples from the anterior 
vitreous phase. With or without an infusion line. If infusion line is 
used, specimen will be diluted and an additional sclerotomy is to be 
made. But the fluid can be suctioned by passing through a 0.45 
micropore filter. 
The ideal recommended stain and culture techniques 
 The specimen is placed in a slide air dried and fixed in 95% 
methyl alcohol and is used for Gram staining, Giemsa staining , 
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Gomori methanamine silver and Calcofluor white staining. 
Smear although provide rapid diagnosis, its less specific and 
sensitive. 
 Inoculating the sample into blood agar plate and streaking 
carefully with a needle and incubating at 37degree C for 
identifying aerobic organisms. 
 Inoculating the sample into chocolate agar plate and incubating 
at 37 degree C enriched with 10%CO2. 
 Inoculating into thioglycolate broth and incubated at 37 degree 
C for anaerobes and microaerophilic organisms such as 
pseudomonas. 
 Inoculating into Sabourauds dextrose agar medium and 
incubated at 25-27degree C to identify fungal growth. 
Direct plating is always better than sending the sample in media. If 
direct plating is not possible sample should be sent as soon as possible 
for Grams and Giemsa. The lid margin and conjunctival swaps are not 
recommended. In case of endophthalmitis with sutural abscess culture 
of the removed suture is recommended. 
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A culture is defined as positive if the same organism grows in more 
than one medium. It is called equivocal growth if the organism grows 
only in liquid medium and scanty growth in solid medium.   
Cultures usually require 24 to 48 hours for initial results and need to 
be checked daily. Vitreous culture tap has got more sensitivity and 
specificity than aqueous tap. Culture should be examined for 2 weeks 
in the case of aerobic and anaerobic before reporting as negative. In 
case of fungal culture minimum 3 weeks should be observed. In 40 to 
50% of the cases, culture will be negative. In those cases, molecular 
diagnosis play an important role in the diagnosis since in many cases 
in the absence of culture growth, there may be confusion in the 
diagnosis and treatment.  
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BLOOD AGAR SHOWING STAPH. AUREUS GROWTH 
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CULTURE PLATE SHOWING ZONE OF INHIBITION AROUND 
STAPH. AUREUS 
 
 
 
CULTURE TUBE SHOWING ASPERGILLUS FLAVUS 
  
41 
 
 
 
MOLECULAR DIAGNOSIS 
 
Molecular diagnosis is the most sensitive and specific for the 
identification of organisms from the vitreous cavity. These are 
versatile methods of DNA amplification. They mainly include 
 Polymerase chain reaction (PCR)  
 Ligase chain reaction ( LCR) 
 Fluorescein amplified fragment length polymorphism 
(FAFLP) 
 Enterobacterial repetitive intergenic consensus PCR (ERIC 
PCR) 
 Labelled nucleic acid probe methods 
 PCR insitu hybridisation 
Polymerase chain reaction (PCR) - is an advanced molecular 
biology technique used to amplify a single copy of a piece 
of DNA across high order magnitude, generating millions of copies of 
a particular DNA sequence. It allows the exponential amplification of 
impure DNA starting material. Main advantage is rapid positivity and 
the high sensitivity and specificity. 
42 
 
 
 
Ligase chain reaction - is similar to PCR. Here two nucleotide 
chains will be hybridised to a DNA template and ends are juxtaposed. 
DNA ligase which is obtained from T4phage joins the 2nucleotide 
sequence into single fragment. Repeated cycles of annealing and 
ligation generates exponential amplification of the target sequence. 
Enterobacterial repetitive intergenic consensus PCR (ERIC PCR) 
- Enterobacterial repetitive intergenic consensus sequences are 127-bp 
imperfect palindromes occurring in multiple copies in the genomes of 
enterobacteria and vibrios.
30
 These palindromes will be distributed in 
wide variety of species. ERIC-PCR can be used to establish the clonal 
relationship between clinical and environmental isolates such as to 
find the reason in an outbreak of postoperative endophthalmitis. (For 
eg. Contaminated air condition system) 
Fluorescein amplified fragment length polymorphism (FAFLP) -  
FAFLP is an advanced PCR based fingerprinting technique that can 
detect polymorphism in the whole genome level with very high 
sensitivity. 
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MEDICAL MANAGEMENT OF 
ENDOPHTHALMITIS 
 
Objectives of endophthalmitis treatment 
 Control or to eradicate infection 
 Manage complications 
 Restoration of vision 
 Symptomatic relief 
 Prevent panophthalmitis 
 Maintain the globe integrity. 
The mainstay of endophthalmitis treatment is administration of broad 
spectrum intravitreal antibiotics. 
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ANTIMICROBIAL THERAPY 
 
 Topical drugs: the ocular penetration is poor. Topical antibiotics 
are useful in treating coexistent problems as corneal ulcer, 
sutural abscess. 
 Sub conjunctival: anterior chamber penetration is more. But the 
vitreous penetration is poor. 
 Periocular: anterior or posterior sub Tenon injection can be 
given. Gives more concentration of the drugs and act as a depot. 
 Intravitreal: is the principal modality of treatment. It would be 
ideal to identify the causative agent and to administer specific 
antibiotics. This is not always practical as it takes time and time 
delay in initiating the treatment worsens the prognosis. So broad 
spectrum antibiotics (two drug regimen) is advocated. First 
Choice is injection Vancomycin and Ceftazidime combination. 
Second choice is injection Vancomycin and Amikacin 
combination. Vancomycin provides good cover for Gram-
positive bacteria including methicillin-resistant staphylococci. 
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Ceftazidime is used to cover the Gram-negative spectrum incl. 
Ps. Aeruginosa. 
Method: 
 Under topical anaesthesia, 5% povidone iodine is instilled and 
washed. 
 Speculum is inserted. 
 Using a 26G needle the site of insertion is marked from the 
limbus.3mm(aphakic) 3.5mm (pseudophakic) 4mm (phakic) 
 0.2ml of fluid is aspirated to be send for culture and 
sensitivity. 
 Through the same needle inject the prepared antibiotics drop 
by drop avoiding jet formation. 
 The bevel should be facing upwards and the direction of 
penetration should be towards mid-vitreous. 
 IOP should be checked at the end of procedure and needle is 
withdrawn. 
 Sub conjunctival injection of antibiotics is given. 
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METHOD OF GIVING INTRAVITREAL ANTIBIOTICS 
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Systemic antibiotics: ocular penetration of systemic antibiotics is 
significantly reduced by the blood retinal barrier. Cefazolin, 
Ceftazidime has got better penetration in inflamed eyes. Systemic 
antibiotics have great significance in endogenous endophthalmitis 
where there is a focus in the choroid or retinal layers.   
STEROIDS IN ENDOPHTHALMITIS TREATMENT 
Corticosteroids are recommended as an important adjunct to 
antibiotics and vitrectomy in the management of infectious bacterial 
endophthalmitis. Corticosteroids limit the degree of inflammation 
caused by toxins liberated from the micro-organisms. The 
Endophthalmitis Vitrectomy Study (EVS) recommends oral 
prednisolone (1 mg/kg body weight), starting a day after the 
intraocular antibiotic (IOAB) therapy, with or without vitrectomy. But 
has no independent role in visual outcome. Intravitreal 
dexamethasone is recommended in patients who cannot take systemic 
prednisolone. 
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SPECIFIC ANTIBIOTIC OF CHOICE FOR TREATMENT OF 
BACTERIAL ENDOPHTHALMITIS 
Microorganism 
Intravitreal 
antibiotic 
Systemic therapy 
Topical/sub 
conjunctival 
Staphylococcus 
Vancomycin / 
Cefazolin 
Cefazolin Cefazolin 
Streptococcus 
Vancomycin / 
Cefazolin 
Cefazolin + Ampicillin Cefazolin 
Haemophilus Chloramphenicol Ceftazidime Ciprofloxacin 
    
Propionibacterium Vancomycin Penicillin Vancomycin 
    
Corynebacterium 
Vancomycin + 
Cefazolin 
Cefazolin Cefazolin 
    
Bacillus 
Clindamycin + 
Amikacin 
Clindamycin + 
Gentamicin 
Clindamycin + 
Gentamicin 
    
Listeria Ampicillin+ Ampicillin Vancomycin 
 
Vancomycin 
  
Clostridium 
Clindamycin / 
Penicillin 
Clindamycin Clindamycin 
    
Nocardia Amikacin Trimethoprimsulfa Amikacin 
    
Pseudomonas 
Amikacin / 
Ceftazidime 
Ciprofloxacin Amikacin 
    
Proteus 
Gentamicin + 
Cefazolin 
Cefazolin + 
Ciprofloxacin 
Gentamicin 
    
Serratia Amikacin 
Gentamicin + 
Ciprofloxacin 
Gentamicin 
    
Klebsiella Amikacin Gentamicin + Cefazolin 
Gentamicin + 
Cefazolin 
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STANDARD RECOMMENDED DOSES FOR INFECTIOUS 
ENDOPHTHALMITIS 
 
TOPICAL 
 
DRUG CONCENTRATION  DOSAGE  
Cefazolin  50mg/ml  Hourly during day time  
     
Gentamicin 15mg/ml  Two hourly during night  
     
Natamycin  5%    
     
Corticosteroids    8TD  
(Predforte acetate) 1%    
     
Atropine  1%  BD  
Sulphate      
 
SYSTEMIC 
 
Vancomycin 1gm IV 12
th
 hourly 
Cefazolin 1.5gm IV 6
th
 hourly 
Ceftriaxone 2gm IV 8
th
 hourly 
50 
 
 
 
Ciprofloxacin 750mg 12
th
 hourly 
Chloramphenicol 1gm IV 8
th
 hourly 
Amikacin 240mg 8
th
 hourly (15mg/kg/day) 
Tobramycin  80mg 8
th
 hourly (5mg/kg/day) 
 
ANTIFUNGAL 
  
Amphotericin B 0.7-1mg/kg/day (given slow IV over 2 to 6 hours) 
  
Fluconazole 200mg/day in single or divided doses 
  
Ketoconazole 400mg/day in dingle or divided doses 
  
Flucytosine  50-100mg/kg/day 
  
Voriconazole  6mg/kg BD for the 1
st
 day followed by 4mg/kg BD 
as a maintenance dose 
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INTRAVITREAL ANTIBIOTICS AND ANTIFUNGALS 
 
Vancomycin 1mg in 0.1ml 
  
Amikacin 400ugm in 0.1ml 
  
Voriconazole  50ugm in 0.1ml 
  
Cefazolin  2.25mg in 0.1ml 
  
Gentamycin  100ugm in 0.1ml 
  
Amphotericin B  5ugm in 0.1ml 
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PREPARATION OF INTRAVITREAL INJECTIONS 
 
DRUG VIAL 
SIZE 
DILUENT 
in ml 
CONC 
in 1ml 
ALIQUOT 
(ml) 
FINAL 
conc/ml 
INTRA 
VITREAL 
DOSAGE 
/0.1ml 
Vancomycin 500mg 10 50mg 0.2ml 10mg 1mg 
 powder      
Cefazolin 500mg 2 250mg 0.1ml 22.5mg 2.25mg 
 powder      
Amikacin 100mg  50mg 0.2ml 4mg 0.4mg 
 In 2ml   Add 2.3ml   
Gentamycin  80mg  40mg 0.1ml 2mg 0.2mg 
 In 2ml   Add 1.9ml   
Voriconazole 200mg 20 10mg 1ml 1mg 0.1mg 
 powder   Add 9ml   
AmphotericinB 50mg 10 0.5mg 0.1ml 0.05mg 5ugm 
 powder   Add 9.9ml   
Dexamethasone  8mg  
In  2ml 
 4mg 0.1ml 0.4mg 0.4mg 
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SURGICAL MANAGEMENT IN 
ENDOPHTHALMITIS 
 
The gold standard of treatment of acute post-operative 
endophthalmitis is immediate "complete" three port pars plana 
vitrectomy. Vitrectomy is technically more demanding, needs 
experience. Vitrectomy may be primary during acute infections to 
decrease the microbial load or secondary in the resolved stage for 
removal of membranes. 
Indications: 
 Visual acuity of perception of light at presentation 
 Worsening of the clinical scenario after 48hours of treatment. 
 Endophthalmitis associated with retained intraocular foreign 
body. 
 Fungal endophthalmitis. 
 Chronic endophthalmitis with remissions. 
 Delayed vitrectomy once the infection has been controlled and 
with presence of multiple vitreous opacities and membranes. 
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 Advantages: 
 Decrease microbial load 
 Decrease the amount of inflammatory mediators 
 Better diffusion and penetration of antibiotics 
 Provide good material for culture 
 Removes media opacities 
 Removes the vitreous scaffold for the formation of scar and 
vitreous membranes which could lead to tractional retinal 
detachment. 
Disadvantages: 
 Poor visualisation due to oedematous cornea, membranes or 
cheesy material stuck to the pupil. 
 Iatrogenic retinal breaks or detachment while pulling the 
vitreous strands. 
 Bleeding from conjunctival and episcleral vessels 
 Associated choroidal detachment making placement of infusion 
cannula difficult. 
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STEPS: 
Done under peribulbar or retrobulbar anaesthesia. The infusion port is 
inserted through the pars plana, 3.5mm from the limbus, but is not 
turned on. The vitreous cutter is inserted through a separate 3.5mm 
sclerotomy and directly visualised through the pupil. A hand-held 
syringe is attached to the aspirating line and fluid is aspirated whilst 
the surgeon activates the cutter until the eye visibly softens. The 
infusion is turned on to reform the globe and the cutter removed. The 
syringe and the tubing now contain 1-2ml of infected, undiluted 
vitreous are promptly sent to the laboratory for immediate Gram stain, 
culture and PCR analysis. 
The vitreous cutter is now connected to the machine for aspiration 
control and a light pipe is inserted through the pars plana. A standard 
three-port vitrectomy is performed within the limits of visualisation. It 
is better to do a posterior capsulotomy with the cutter and aspirate the 
fibrin and pus from the anterior chamber and intraocular lens surface. 
This procedure not only improves visualisation but permits flow 
through the entire eye and facilitates recovery. Caution must be 
exercised against too aggressive surgery 
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Once the vitrectomy is as complete as possible, the intravitreal 
antibiotics are injected. The dose should be reduced by 50% if a full 
vitrectomy has been performed. This injection should be given 
slowly, the needle pointed away from the macula. The important 
points to be considered are use maximal cutting rate, minimal suction 
and never go very close to retina. 
 
 
 
THREE PORT PARSPLANA VITRECTOMY 
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ENDOPHTHALMITIS VITRECTOMY 
STUDY (EVS) 
 
EVS was a multicentric randomized clinical trial conducted in 420 
patients who developed bacterial endophthalmitis within 6 weeks of 
cataract surgery. 
PURPOSE 
 To determine the role of initial pars plana vitrectomy in  
comparison to intravitreal injection alone in the management of 
postoperative bacterial endophthalmitis 
 To determine the role of intravenous antibiotics in the 
management of bacterial endophthalmitis 
 To determine which factors, other than treatment, predict 
outcome in post-operative bacterial endophthalmitis. 
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CONCLUSIONS: 
 If initial vision is hand movements or better there was no 
difference in outcome between immediate vitrectomy and 
intravitreal antibiotics. 
 If initial visual acuity is only PL then the visual outcome and 
media clarity was substantially better in the group undergoing 
initial vitrectomy than in patients receiving intravitreal 
antibiotics alone. 
 No difference in final visual acuity or media clarity with or 
without systemic antibiotics. 
 EVS identified 9 baseline risk factors of poor outcome. They 
included old age, diabetics, presence of corneal infiltrate, 
disrupted posterior capsule, low(<5mm) or high (>25mm)IOP, 
RAPD, rubeosis iridis, absent red reflex. 
 
LIMITATIONS OF EVS: 
 EVS included only acute postop endophthalmitis not the more 
aggressive post traumatic, bleb induced or endogenous 
endophthalmitis. 
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 80% of the cases in EVS were due to coagulase negative 
staphylococci which responds to intravitreal antibiotics. So the 
conclusion was based on that. But in the clinical scenario with 
other bacteria like streptococci may need urgent vitrectomy in 
order to remove the highly inflammatory bacterial cell wall from 
the vitreous. 
 EVS showed difference between the diabetic and nondiabetic. 
But the results were not statistically significant because of the 
less number of diabetic participants in the study.  
 EVS didn’t include the use of steroids in endophthalmitis. 
Revised EVS studies all recommend the use of steroids. Steroids 
serve as the main anti-inflammatory agent in endophthalmitis 
treatment. Systemic steroids should be administered to all 
patients after ruling out systemic contra indications. In those 
cases one dose of intra vitreal steroid can be used. Steroids are 
contraindicated in fungal endophthalmitis. 
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ESCRS, EUROPEAN SOCIETY OF CATARACT & 
REFRACTIVE SURGEONS STUDY IN ENDOPHTHALMITIS 
 
The ESCRS study evaluated effects of an intracameral injection of 
Cefuroxime 1mg at the close of surgery and compared postoperative 
endophthalmitis rates with other study groups that included 
perioperative antibiotic drops, and control. ESCRS was a 2x2 factorial 
design in prospective, randomized fashion conducted in 16000 
patients. 
4 groups were allocated 
Group A: no perioperative drops or injection 
GroupB: placebo eye drops and intracameral 1mg Cefuroxime 
injection  
Group C: topical Levofloxacin eye drops, no injection. 
Group D: topical Levofloxacin with intracameral Cefuroxime. 
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RESULTS: 
 The risk for contracting postoperative endophthalmitis was 
significantly reduced – 5 fold by an intracameral injection of 
1mg cefuroxime at the close of surgery. 
 Lowest incidence rate was observed in Group D 
 5.88 fold increase in risk of postoperative endophthalmitis in 
clear corneal incision compared to sclerocorneal tunnel. 
  3.13 fold increase in risk in use of silicon IOL compared to that 
of acrylic IOL.  
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RECOMMENDED PROPHYLAXIS FOR POST OPERATIVE 
ENDOPHTHALMITIS  
It is very important to take meticulous precautions to ensure sterility 
and total asepsis at the time of surgery. As said prevention is always 
better than cure, strict aseptic precautions is the most important 
measure in controlling the occurrence of endophthalmitis.  
Emphasis must be given to four key sources of contamination as 
 
Patient Personnel Instruments Environment 
 
It’s a proven fact that the most common source of organisms in post-
operative endophthalmitis is residual flora from the conjunctival sac. 
This encourages the habit of using antibiotics in the preoperative 
period. Ideally topical antibiotics must be applied for about 3 days 
preceding the surgery. As the incidence of endophthalmitis increases 
with uncontrolled diabetes and in presence of focal sepsis, care must 
be given to both in the pre-operative period. Syringing must be done 
in all patients before cataract surgery. In case of any purulent 
regurgitation, endonasal or external DCR or DCT must be performed.  
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Placing half strength of povidone iodine solution (5%) in the 
conjunctiva sac for a minimum of 3 minutes just before surgery, 
considerably decreases the bacterial load.  There is an increased risk 
of carrying the residual flora into the posterior chamber while 
inserting the lens. The practice of using povidone iodine reduces that 
risk also. Povidone iodine has strong antibacterial, antifungal and 
antiviral properties. 
Use of sub conjunctival and intracameral antibiotics
9
 at the end of 
surgery considerably reduces the incidence of endophthalmitis. 
SURGICAL ASEPSIS AND STERILIZATION 
Word sepsis means “I putrefy” 
Sterile surgical technique and asepsis remains the main pillar for 
protecting the eye as eyes are extremely delicate organs. Asepsis 
means rendering free of pathogenic organisms whereas sterilization 
means rendering free of all living organisms including both vegetative 
and spore form. 
Asepsis of the operating room should be planned in such a way that it 
keeps the flow traffic only from clean areas to dirty ones and it should 
prevent cross contamination. Theatre should be in a blind wing with 
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controlled laminar air flow system. Outside air will be filtered and 
then circulated after moisturization with optimal humidity. Ideally 
every hour there should be 16 air exchanges. 
Theatre sterilization should be done atleast once in a week.  Usual 
method used is washing the floor with water followed by formalin 
vapour fumigation. Room should be then closed for 6 hours followed 
by carbolisation with 2% carbolic acid. The other method is to use 
Aldekol mixture (6% gluteraldehyde +6% formaldehyde +5% 
benzalkonium chloride). Room should be closed for 2 hours. It’s a 
faster method of sterilization.  
 
PERSONNEL AND THEATRE ASPECTS 
As these cannot be sterilized, personnel remain the greatest source of 
contamination. Dress code should be strictly maintained. It includes 
laundered dress, a disposable cap that covers all the scalp hair and a 
face mask (high filtration 95%) that completely covering the nose and 
mouth.  
 
 
65 
 
 
 
RECOMMENDED WAY OF SURGICAL HANDWASHING
31
 
 All jewellery must be removed before washing 
 Wash hands and arms with an antimicrobial soap in luke warm 
water. 
 First clean subungual areas  
 Scrub each side of each finger, between the fingers, and the 
back and front of the hand for two minutes. Start timing. 
 Followed by scrubbing of the arms, keeping the hand higher 
than the arm at all times. This prevents bacteria-laden soap and 
water from contaminating the hand. 
 Wash each side of the arm to three inches above the elbow for 
one minute. 
 Repeat the process on the other hand and arm. If the hand 
touches anything and becoming unsterile, the scrub must be 
lengthened by one minute for the area that has been 
contaminated. 
 Rinse hands and arms with water passing only in one direction 
only, from fingertips to elbow. Proceed to the operating room 
holding hands above elbows. 
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 During the scrub, care should be taken not to splash water onto 
surgical attire. 
 Once entering the operating room, hands and arms should be 
dried using a sterile towel in aseptic technique. 
DON’T’S   IN THEATRE STERILISATION 
 Rushing through surgical scrubbing. 
 Preparing the trolley by an unsterile person with chittle forceps. 
 Continuing surgery in a doubtful sterile technique. 
 Preparing the trolley long before the need. 
 Wearing a cap that not fully covering the scalp hair. 
 Wearing a mask that not covering nose and mouth. 
 Throwing blood contaminated substances into theatre floor. 
 Scrubbed persons keeping their hands folded.  
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RECOMMENDED PROPHYLACTIC MEASURES 
Pre-Operative 
 Preoperative assessment of the patient for all risk factors such 
as diabetes, focal sepsis. 
 Syringing for all cataract patients. 
 Treatment of eyelid infections. 
 Controlling of all systemic infections. 
 Prophylactic topical antibiotic therapy atleast 24 hours prior 
to the surgery. 
  Intra-Operative 
 Sterile draping to exclude eyelashes and lids from the field of 
operation. 
 Using  an adhesive such as opsite.  
 5%povidone iodine to paint the ocular and periocular surfaces. 
Half the strength is applied inside the palpebral conjunctiva and 
allowed to be in place for minimum 3 minutes before washing. 
 Flushing the IOL with sterile water before insertion. 
 Minimize the duration of IOL exposure prior to insertion. 
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 In case of any PC rent and vitreous loss, vitreous must be 
cleared from the AC and sutures must be applied. 
 Careful wound closure. There should not be exposure of the 
sclerocorneal tunnel. Always cover it with conjunctiva. 
 Intracameral injection of antibiotic at the end of surgery. 
 
Post-Operative 
 Appropriate use of postop antibiotics and steroid combination. 
 Careful follow up. 
 Suture removal under strict aseptic precautions. 
 Creating awareness in the patients that in any case of pain or 
decreased vision seek the help of an ophthalmologist 
immediately.  
 
 
 
 
 
 
 
 
 
 
Part II 
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AIM OF THE STUDY 
 
 To evaluate the clinical presentations and assess visual 
outcomes of Endophthalmitis. 
 To evaluate the various etiological factors and predisposing 
factors leading on to endophthalmitis. 
 To assess the clinical presentation in different types of 
endophthalmitis. 
 Whether the treatment is controlling or eradicating the infection 
and giving symptomatic relief to the patient. 
 Whether the treatment is preventing secondary complications   
such as panophthalmitis. 
 To assess efficacy and visual outcome after medical and surgical 
intervention (including intravitreal antibiotics and PPV).  
 
 
 
 
71 
 
 
 
METHODOLOGY: 
 
PATIENT SELECTION: All cases (including referred cases from 
outside) attending the ophthal department with typical signs and 
symptoms of endophthalmitis during the study period October 2013 to 
August 2014 were registered, evaluated, managed and followed up. 
 
INCLUSION CRITERIA: A series of 50 patients with typical 
symptoms and signs of endophthalmitis such as loss of vision, 
anterior segment and posterior segment findings which was confirmed 
with an Ultrasound report (B Scan). Both genders were included. Age 
was not as a part of this study. 
EXCLUSION CRITERIA: 
 Patients who were unwilling to undergo interventional therapy. 
 Patients who lost for follow up. 
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MATERIALS AND METHODS 
 
For all 50 patients included in the study, a detailed history was taken 
with special emphasis on the mode of insult including intraocular 
surgeries, trauma, focal sepsis and systemic diseases. All patients 
included in the study were evaluated first by measuring the visual 
acuity using Snellen’s chart. Anterior segment was thoroughly 
examined by slit lamp biomicroscopy. Posterior segment was 
examined with indirect ophthalmoscope. Vitritis grading was done for 
all the patients. Ultrasound (B scan) was done for all patients to 
confirm the diagnosis, to rule out intra ocular foreign body and to rule 
out associated choroidal or retinal detachment. 
All basic necessary investigations such as random blood sugar, blood 
pressure, complete hemogram, X-ray orbit was done. General 
examination with special emphasis to rule out septic foci such as 
dental caries, dacryocystitis were also done. Vitreous tap was taken 
from all the patients and was subjected for grams stain, KOH stain 
and culture and sensitivity. 
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METHODS OF COLLECTING SPECIMEN: 
Under topical anaesthesia, 5% povidone iodine is instilled into the eye 
and washed. Speculum is inserted. Using a 26G needle attached to 
tuberculin syringe, the site of insertion is marked on the 
superotemporal aspect of sclera 3mm (aphakic) 3.5mm 
(pseudophakic) 4mm (phakic) from the limbus.0.2ml of fluid is 
aspirated. The syringe is capped and labelled and sent to the lab 
immediately.  
 
TREATMENT PROTOCOL: 
Treatment decision was based on the visual acuity at the time of 
presentation. For all cases of endophthalmitis (early or late postop and 
traumatic endophthalmitis) with visual acuity of hand movements or 
better was treated with intravitreal antibiotics. The possibility of 
choroidal detachment which is a contraindication for intravitreal 
drugs was ruled out by taking Bscan. The choice of antibiotics 
Vancomycin 1mg in 0.1ml and Amikacin 400 ugm in 0.1ml, given as 
early as possible after taking the vitreous tap. The vitreous sample 
will be sent for culture and sensitivity results. In case of any post-
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operative wound dehiscence, wound repair was done. If associated 
with iris tissue prolapse, iris abscission with wound suturing was 
performed. 
All cases were treated as inpatients. Simultaneously systemic 
antibiotics and topical antibiotics were given. The choice of topical 
antibiotic was broad spectrum 0.5% Moxifloxacin hourly. 
Cycloplegics such as 1% atropine eye drops BD or Cyclopentolate 
eye drops TDS was also given. Systemic steroids were given to all 
patients (T.Prednisolone 1mg/kg/body weight OD) after ruling out 
systemic contraindications such as diabetes and hypertension. In such 
situations, intravitreal Dexamethasone of 400ugm in 0.1ml was given. 
But in suspicion of fungal endophthalmitis, both systemic and 
intravitreal steroids were avoided.  
Culture and sensitivity reports are collected after 48 hours. In case of 
any strong suspicion of fungal endophthalmitis or culture showing 
fungal growth intravitreal Voriconazole 50ugm in 0.1ml was given. 
Systemic T. Ketoconazole 400mg was given for 14 days duration. 
In case of any improvement in the visual acuity or symptoms or signs 
repeat intravitreal antibiotics were given in selected patients at an 
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interval of 72 hours. Maximum 3 doses were given. Those cases of 
worsening of signs or visual acuity were proceeded with core 
vitrectomy. 
All cases of endophthalmitis with vision of perception of light were 
treated with core vitrectomy, if the onset was acute or visualisation of 
the vitreous cavity was present. Other cases were treated with 
intravitreal antibiotics for the containment of the infection. 
Uncontrolled infections with no perception of light were given the 
option of evisceration with systemic antibiotics. 
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OBSERVATION AND DISCUSSION 
 
The clinical study on endophthalmitis was conducted at the Regional 
Institute of Ophthalmology, Government Ophthalmic Hospital, 
Chennai. 50 cases were studied over a period of eleven months. Out 
of 50 patients included in the study 24 cases were from our institute 
and 26 cases were referred from other hospitals. The various 
observations in our study are discussed below.  
 
OCCURRENCE OF VARIOUS FORMS OF ENDOPHTHALMITIS   
 
Among the 50 cases, 25 cases (50%) were postoperative, 22cases 
(44%) were post traumatic, 2 cases (4%) were secondary to perforated 
corneal ulcer and 1 case (2%) was endogenous endophthalmitis. 
 
Post-Operative Post Traumatic Perforated Ulcer Endogenous 
25 (50%) 22 (44%) 2 (4%) 1 (2%) 
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POST OPERATIVE ENDOPHTHALMITIS 
 
Out of the 25 post-operative cases, 14 cases were referred from 
outside. 44%of the cases were following SICS with PCIOL. Out of 25 
cases PC rent was documented in 8 cases. Out of the 5 Phaco cases, 2 
cases were clear corneal sutureless incision. 
 
ECCE 
SICS Lens 
Removal 
SICS 
PCIOL 
Phaco 
Foldable 
AG Keratoplasty RD 
Sec 
IOL 
2 (8%) 2 (8%) 11 (44%) 5 (20%) 2 (8%) 1 (4%) 1 (4%) 1 (4%) 
 
POST TRAUMATIC ENDOPHTHALMITIS 
 
Of the 22 cases of endophthalmitis following penetrating ocular 
trauma, 6 cases followed injury with metal rod, 5 cases following road 
traffic accident, 5 cases following injury with stick, 3 cases following 
injury with plastic rod, 2cases following injury with cardboard box 
and 1 case following fish hook injury. 2 cases were associated with 
retained intra ocular foreign body (IOFB). 
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MODE OF PRESENTATION 
 
Acute Intermediate Delayed 
24 (48%) 10 (20%) 16 (32%) 
 
2 cases with fulminant onset was associated with Pseudomonas 
infection.  Majority of the acute onset endophthalmitis was associated 
with Staph. Epidermidis.  
 
SEX DISTRIBUTION 
Male Female 
29 (58%) 21 (42%) 
 
There was a slight preponderance in the incidence of endophthalmitis 
in males. 58% as compared to females (42%)  
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AGE DISTRIBUTION 
Age Endogenous 
Perforated 
Ulcer 
Post Trauma 
Post 
Op 
1 - 10 1 - - - 
11 - 20 - - 4 1 
21 - 30 - - 5 - 
31 - 40 - - 6 3 
41 - 50 - - 2 4 
51 - 60 - - 3 7 
61 - 70 - 2 2 9 
71 - 80 - - - 1 
 
 Only one case of endogenous endophthalmitis was reported and 
the age was less than 10 years. 2 cases of perforated corneal 
ulcer came under the age group between 61 and 70.  
 The incidence of post-traumatic endophthalmitis was more 
common in age group less than 40 years.  
 Maximum age incidence of post-operative endophthalmitis was 
between 51 and 70, which is the most common age group 
undergoing cataract surgery. 
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ASSOSIATED DISEASE 
 
Type Diabetes Focal Sepsis 
Endogenous 0 0 
Perforated Ulcer 2 0 
Post Op 6 5 
Post Trauma 2 1 
 
Out of 50 cases, 10 cases had Diabetes mellitus. 6 patients were 
known cases of diabetes on treatment. 3 cases had uncontrolled 
hyperglycemia. Out of the 4 eviscerated cases, 3 cases had diabetes. 
Pre-existing diabetes is not been confirmed as an isolated risk factor 
for post-op endophthalmitis. According to EVS, endophthalmitis in 
diabetics is caused more often by Gram-negative organisms; our study 
also showed the same finding. In the EVS, endophthalmitis patients 
with diabetes benefited from vitrectomy when their initial vision was 
better than light perception. In our study one patient with diabetes 
underwent core vitrectomy improved vision from HM to 6/18. 
Septic focus was found in 6 patients (5 Post-Operative and 1 Post 
Traumatic Endophthalmitis). 2 patients had sinus infection, diagnosis 
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confirmed by X RAY paranasal sinuses. 2 patients had associated 
dacryocystitis who later underwent DCT. 2 patients had caries tooth. 
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SMEAR REPORT 
 
Sample 
Grams Stain KOH 
Stain 
Smear 
Positivity GPC GNB GPB 
Vitreous  8 2   1 4  14 
 
CULTURE REPORT 
 
Sample S.EPI S.AUR ASP PSEUDO BACILLUS 
Vitreous  7  3  4 2   1 
 
17 cases out of 50 showed culture positive results. (34%) 
Staphylococcus Epidermidis was the most common isolated 
organism. 
From 3 cases, Staphylococcus Aureus was isolated. Aspergillus was 
cultured from 3 cases. Pseudomonas from 2 cases and Bacillus 
species from one case. 
14 cases showed smear positivity reports. All 4 aspergillus cases were 
KOH smear positive. 
Vitreous culture and sensitivity was found to be more specific and 
sensitive compared to vitreous smear positivity. 
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VISUAL RECOVERY FOLOWING MANAGEMENT 
 
VISUAL RECOVERY IN VARIOUS MODES OF ENDOPHTHALMITIS 
 
Visual 
Acuity 
Endogenous 
Perforated 
Ulcer 
Post-
Operative 
Post 
Traumatic 
Initial Final Initial Final Initial Final Initial Final 
NO PL 1 1 1 - 8 6 8 7 
PL+ - - 1 1 5 3 7 3 
HM - - - - 6 4 4 2 
CFCF - - - - 2 1 2 2 
1/60 - - - - 2 1 1 1 
2/60 - 6/60 - - - - 2 6 - 5 
>6/60 - - - - - 3 - 1 
 
VISUAL RECOVERY IN COMPARISON WITH INITIAL VISUAL ACUITY 
 
VA at 
Presentatio
n 
Total 
Patient
s 
EVI
S 
NIL 
Improvemen
t 
Visual Recovery (VR) 
Poo
r 
Satisfactor
y 
Goo
d 
NO PL 17 4 13 - - - 
PL+ 13 - 7 3 2 1 
HM 11 - 3 2 5 1 
CFCF 4 - 1 1 2 - 
1/60 3 - - - 2 1 
> 1/60 < 
6/60 
2 - - - 1 1 
> 6/60 - - - - - - 
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34% (17) of the endophthalmitis cases presented with no perception 
of light. 4 of the patient had uncontrolled spreading infection. Infected 
eye was eviscerated in fear of complications as panophthalmitis. The 
other 13 patients were given atleast one dose of intravitreal 
antibiotics. The same resulted in containment and non-progression of 
the infection. But these group showed no visual improvement with 
intravitreal antibiotics. 
26% (13) of the cases presented with vision of perception of light. Of 
those, 6 patients underwent core vitrectomy. All 13 patients were 
treated with intravitreal antibiotics. 7 patients out of 13 (54%) showed 
no improvement in the vision. 3 patients showed poor visual recovery. 
(<=1/60) 2 patients showed satisfactory visual recovery (2/60- 6/60).  
And 1 patient got good visual recovery who regained vision upto 
6/36. 
22% (11) patients presented with vision of hand movements. All 
patients were treated with intravitreal antibiotics. Of which 2 had poor 
visual recovery, 5 with satisfactory visual recovery and 1 with good 
visual recovery. 
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8% (4) cases presented with vision of counting finger close to face. Of 
that 2 had satisfactory and 1 had poor visual recovery. 
Only 10% of the cases presented with vision >1/60. Of which 60% 
had satisfactory visual recovery and 40% had good visual recovery 
following intravitreal antibiotics.  
Patients who had better visual acuity at the time of presentation, final 
visual acuity was also better. Patients who presented relatively late 
(more than 1 week) of having the symptoms had poor visual outcome. 
The patients who had dense vitritis also had poor visual outcome. 
Those patients with positive culture and infection with highly virulent 
organisms had poor visual outcome. 2 patients with fungal infection 
with aspergillus were found to resistant to treatment and was 
associated with very poor visual outcome.  
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VISUAL OUTCOME AFTER MEDICAL AND SURGICAL 
THERAPY 
 
Visual Outcome Intravitreal AB 
Core vitrectomy + 
Intravitreal AB 
Poor 17 5 
Satisfactory 12 2 
Good 4 1 
 
Out of 50 patients, 49 patients were given intravitreal antibiotics. One 
patient had uncontrolled spreading infection which was eviscerated 
immediately. All patients had symptomatic improvement. But the 
visual outcome was unpredictable. 13 patients had no perception of 
light. 1 patient had poor visual recovery. 12 patients had satisfactory 
recovery and 4 patients had good visual recovery.  
8 patients underwent core vitrectomy. All patients were given 
intravitreal antibiotics also. The major criterion to select for the 
procedure was visualisation of the vitreous cavity and the perception 
of light at the time of presentation. Of which 5 patients had poor 
visual recovery, 2 had satisfactory and 1 had good visual recovery. 
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One patient with vision of hand movements also underwent core 
vitrectomy who regained his vision up to 6/18. 
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SUMMARY 
 
 Out of the 50 cases of endophthalmitis included in our study, 24 
cases were from our institution. 26 cases were referred from 
other hospitals. 
 Four different entity of endophthalmitis were included in the 
study namely post-operative, post traumatic, perforated corneal 
ulcer (with no history of ocular trauma) and endogenous 
endophthalmitis. 
 Post-operative endophthalmitis was more common after small 
incision cataract surgery. 
 (50%) were postoperative, (44%) were post traumatic, (4%) 
were secondary to perforated corneal ulcer and (2%) was 
endogenous endophthalmitis. 
 Post-operative endophthalmitis was more common after small 
incision cataract surgery (44%) followed by phacoemulsification 
cataract surgery (20%).  
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 PC Rent with vitreous loss was documented in 32% of the cases 
which is a strong risk factor for the development of 
endophthalmitis. 
 3 out of 5 Phaco surgeries were associated with clear corneal 
sutureless incision. The same is a risk factor for the 
development of endophthalmitis. 
 44% of the cases were secondary to post trauma. Majority of the 
cases were associated with injury in a contaminated 
environment such as road traffic accident. 
 There was a slight preponderance in the incidence of 
endophthalmitis in males. 58% as compared to females (42%). 
 48% of the cases had acute onset endophthalmitis. 10% 
intermediate onset and 32% presented with delayed onset 
endophthalmitis. 
 All postop endophthalmitis cases secondary to Anti glaucoma 
surgery, Penetrating Keratoplasty, internal RD surgery (other 
than cataract surgery) had delayed onset endophthalmitis. 
 62% of the post traumatic cases presented with acute onset 
endophthalmitis.  
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 The incidence of post-traumatic endophthalmitis was most 
common in age group less than 40 years.  
 Maximum incidence of post-operative endophthalmitis was 
between 51 and 70 years, which is the most common age group 
undergoing cataract surgery. 
 There was an increased incidence of endophthalmitis in 
association with systemic diseases as diabetes mellitus. 20% had 
diabetes. 
 12 % of the cases were associated with focal sepsis.  
 34% of the cases were culture positive. 
 The most common organism isolated was gram positive cocci 
Staphylococcus Epidermidis (coagulase negative staphylococci).  
 4 cases were associated with Aspergillus species (2 cases Post-
Operative and 2 cases Post Traumatic of which 1 patient had 
retained intraocular foreign body). All the cases were highly 
resistant to treatment.  
 Vitreous culture and sensitivity was found to be more specific 
and sensitive compared to vitreous smear positivity. 
99 
 
 
 
 Culture positivity was associated with poor treatment outcome 
and poor visual recovery. 
 Ultrasound (Bscan) confirmed the diagnosis in all cases. B scan 
also aided in ruling out associated pathologies such as choroidal 
detachment. Retained intra ocular foreign body was picked up 
in2 cases. 
  4 patients underwent evisceration was associated with highly 
virulent organisms such as pseudomonas and aspergillus. 
 Patients who had better visual acuity at the time of presentation, 
final visual acuity was also better.  
 Patients who presented relatively late (more than 1 week) of 
having the symptoms had poor visual outcome.  
 The patients who had dense vitritis of grade 1V or V had poor 
visual outcome.  
 Systemic steroids were found to give symptomatic improvement 
in the patients. 
 Intravitreal antibiotics helped in containment of the infection to 
a limit even though the visual recovery was highly 
unpredictable. 
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 8 patients underwent core vitrectomy. Of which 5 patients had 
poor visual recovery, 2 had satisfactory and 1 had good visual 
recovery. 
 Visual recovery is highly variable in cases of endophthalmitis.  
 24% of the total cases had satisfactory visual recovery and 8% 
of cases had good visual recovery. 
 Post-operative endophthalmitis patients had better prognosis 
than other categories of endophthalmitis. 
 The more the duration between the onset of symptoms and the 
initiation of the treatment, poorer the visual outcome.  
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CONCLUSION AND RECOMMENDATIONS 
Even in this era of recent advances and technologies, endophthalmitis 
still remain as a devastating complication of intraocular surgeries and 
ocular trauma. Post-operative endophthalmitis remains the most 
common followed by post traumatic endophthalmitis. Incidence of 
endogenous endophthalmitis have considerably decreased.  
Gram positive organisms are the most common isolate in culture. The 
incidence of fungal endophthalmitis have slightly increased and are 
found to be more resistant to treatment. 
Patients who had better visual acuity at the time of presentation, final 
visual acuity was also better. Patients who presented relatively late 
(more than 1 week) of having the symptoms had poor visual outcome. 
The patients who had dense vitritis is associated with poor visual 
recovery. Those patients with positive culture and infection with 
highly virulent organisms had poor visual outcome. 
Post-operative endophthalmitis patients had better prognosis than 
other categories of endophthalmitis. The more the duration between 
the onset of symptoms and the initiation of the treatment, poorer the 
visual outcome. 
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Systemic diseases such as diabetes mellitus, focal sepsis were 
associated with an increased incidence of endophthalmitis. 
Intravitreal antibiotics stay as the first choice therapy in all forms of 
endophthalmitis. Core vitrectomy needs skill and experience. But is 
the gold standard as it removes the bacterial load toxins and helps in 
clearing the ocular media allowing a rapid recovery. 
Ultrasound Bscan is an excellent aid in confirming the diagnosis as 
well as complications. Even though a rapid destroying infection 
endophthalmitis can be controlled if the patient presents soon after 
developing the signs and symptoms and is rapidly intervened with 
intravitreal antibiotics. The visual recovery is highly unpredictable in 
all endophthalmitis cases. 
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RECOMMENDATIONS: 
 Careful and thorough pre-operative assessment of the patients 
posted for cataract surgery should be done. 
 Special emphasis must be given to control the diabetic status 
and focal infection. 
 Strict aseptic precautions throughout the surgery should be 
maintained by the doctors and theatre staff. 
 In case of any intraoperative complication, documentation is 
must especially in referrals. 
 All postoperative patients must use a topical steroid antibiotic 
combination. 
 Early medical intervention should be the protocol in 
endophthalmitis. 
 In case of suspicion of endophthalmitis urgent referral is 
recommended if there is no provision for intravitreal antibiotics. 
 Or else one dose of intravitreal antibiotic and referral to higher 
institutions are recommended. 
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 Systemic steroids are recommended for all patients after ruling 
out other contraindications.  
 Bscan before intravitreal antibiotics is recommended to confirm 
diagnosis and to rule out other complications. 
 Prophylactic antibiotic therapy is recommended in all post 
traumatic patients. 
 Careful follow-up of the patients should be done. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure  
 
  
 
PROFORMA 
 
NAME: 
 
AGE: 
 
SEX: 
 
ADDRESS: 
        
SYMPTOMS 
       
        
        
ONSET 
 
Acute - (1 -14 
Days) 
Insidious - (2 - 4 
Weeks) 
Delayed (> 6 Weeks) 
        
Duration 
       
        
Pain: 
 
Watering: 
 
Congestion: 
 
Def 
Vn:  
        
Discharge: 
 
H/O C/L Wear: 
    
        
H/O Focal 
Sepsis  
Dental: 
 
ENT: 
 
Skin: 
 
        
H/O Previous Treatment: 
      
        
H/O Allergy: 
       
        
H/O Collagen Vascular Disorders/HIV/TB: 
    
        
H/O Trauma: 
       
        
H/O Tetanus 
Immunization: 
 
H/O DM 
 
 
      
  
 
        
Type of 
Surgery:        
        
1. ECCE with/without IOL 
  
2. SICS 
with/without IOL    
        
3.PHACO 
CLEAR 
CORNEAL/SC
LEROCORNE
AL 
   
4. SUTURE 
REMOVAL   
        
5. RETINAL/VITREOUS SURGERY 
 
6. STRABISMUS 
  
        
7. KERATOPLASTY 
  
8. PTERYGIUM 
  
        
9. AG SURGERY 
      
        
INTRA OP COMPLICATIONS 
 
PC RENT 
 
VITREOS LOSS 
 
SUTURED OR NOT 
     
        
SIGNS 
       
        
   
RE 
 
LE 
  
        
LIDS 
 
: 
     
        
CONJUCTIVA 
 
: 
     
        
CORNEA 
 
: 
     
  
 
        
AC 
 
: 
     
        
IRIS 
 
: 
     
        
PUPILS DR : 
     
        
 
CR : 
     
        
LENS 
 
: 
     
        
S/L EXAMINATION 
      
        
CONJUCTIVA 
       
        
AC 
       
        
IRIS 
       
        
PUPILS 
       
        
LENS 
       
        
VITREOUS 
       
        
FUNDUS 
EXAMINATION 
- 
Direct 
Ophthalmoscopy    
        
 
Indirect Ophthalmoscopy - Grade  - 
I/II/III/
IV/V  
        
TENSION: 
       
        
V/A: 
        
        
  
 
INVESTIGATIONS: 
      
        
BLOOD - HB: 
 
TC: 
 
DC: 
 
ESR: 
 
        
URINE: 
 
ALB/SUGAR: 
 
BLOOD SUGAR: 
  
        
USG - B SCAN: 
       
        
VITREOUS TAP: 
SMEA
R   
CULTURE/SENSITIVITY 
 
        
 
GRAMS/KOH 
     
        
MANAGEMENT 
       
        
1 MEDICAL 
      
        
 
a. Topical 
 
b. Systemic c. Intracameral d. Intravitreal 
        
        
        
2 SURGICAL 
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MASTERCHART 
 
SL. 
No. 
Name 
A
ge 
Se
x 
IP NO. 
Onset Asst. Illness Type 
HYPOP
YON 
Vitreous 
Loss 
IDO
vitrit
is 
B 
Scan 
Gm 
Stain 
VIT 
KOH 
Stain 
VIT 
Culture 
VIT 
Visual Acuity INT
RA
VIT
RE
AL 
CV 
A/C IM D DM FS END PT PostOp Initial Final 
1 Manikandan 45 M 493871 + - - - - - - + + + IV + - SH ASP NO PL EVIS 1 - 
2 Mohan 65 M 495203 - + - + + - - + + - IV + - - - CFCF 1/60 2 - 
3 Kathirvel 60 M 492911 + - - + - - - + - - IV + - - - HM 5/60 2 - 
4 Selvi 53 F 496553 - - + - - - - +(K) + - V + - - - NO PL 
NO 
PL 
2 - 
5 Vasumathi 64 M 496477 + - - + - - - + + - V + - - - PL+ 3/60 2 + 
6 Obul Raj 65 M 496421 + - - + - - - + + - V + GPC - S.EPI HM HM 2 - 
7 Chandrasekhar 57 M 486787 + - - + - - - + - + IV + - - - HM 6/18 2 + 
8 Neelakandan 51 M 497021 - - + + - - - +(AG) - - IV + - - - PL+ PL+ 2 - 
9 Bappisha 38 F 493062 - + - - - - - + + - III + - - - 1/60 2/60 2 - 
10 Kanagammal 69 F 496611 + - - - - - - + - + IV + GNB - 
Pseudo 
monas 
NO PL 
NO 
PL 
2 - 
11 Neelakandan 51 M 497021 - - + - - - - + - - IV + - - - CFCF 4/60 3 - 
12 Ramadoss 61 M 467642 - - + - + - - + - - IV + - - - HM 5/60 2 - 
13 Viswanathan 35 M 497870 + - - - - - - + + + III + - - - 2/60 6/36 2 - 
14 Vikas Gandhi 12 M 497627 - - + - - - - + - - III + GPC - S.EPI 1/60 2/60 3 - 
15 Thangam 44 F 477869 - - + - + - - + - + IV + - - S.EPI PL+ CFCF 1 + 
16 Rajamma 53 F 496393 - + - - - - - + - - V + - - - NO PL 
NO 
PL 
1 - 
17 Vasundara 39 F 497701 - - + - - - - +(AG) + - IV + - - - NO PL 
NO 
PL 
2 - 
18 Krishnan 72 M 476539 - - + - - - - + - - IV + - - - NO PL 
NO 
PL 
2 - 
19 Kothandaraman 45 M 490031 - - + - - - - + - - V + GPC - S.AUR NO PL 
NO 
PL 
1 - 
  
 
SL. 
No. 
Name 
A
ge 
Se
x 
IP NO. 
Onset Asst. Illness Type 
HYPOP
YON 
Vitreous 
Loss 
IDO
vitrit
is 
B 
Scan 
Gm 
Stain 
VIT 
KOH 
Stain 
VIT 
Culture 
VIT 
Visual Acuity INT
RA
VIT
RE
AL 
CV 
A/C IM D DM FS END PT PostOp Initial Final 
20 Pachaiammal 63 F 487330 + - - + + - - + - + V + GPB - - PL+ PL+ 1 - 
21 Kuyilmani 69 F 497103 - + - - + - - +(RD) - - IV + - - - HM HM 3 - 
22 Ganeshan 65 M 492738 - + - - - - - + + - V + - - - NO PL EVIS - - 
23 Chinnaswamy 66 M 480113 - - + - - - - + - + III + - - - 2/60 6/60 2 - 
24 Murekeshan 58 M 490493 + - - - - - - + - + IV + - - S.EPI HM HM 2 - 
25 Maina 19 F 499837 + - - - - - + - - - IV + - - - PL+ 6/36 2 - 
26 Kashirajan 54 M 500541 - - + - - - + - + - V + GPC - S.EPI CFCF CFCF 3 - 
27 Varathappa 39 M 500481 + - - - - - + - + - IV + - - - CFCF 2/60 2 - 
28 Chetikaran 37 M 499655 - - + - - - + - - - IV + - - - PL+ PL+ 1 + 
29 Vyakulam 62 F 489812 - + - - - - + - - - IV + - - - PL+ PL+ 2 - 
30 Chentamarai 23 F 499362 + - - - - - + - - - IV + GNB - 
Pseudo 
monas 
NO PL EVIS 1 - 
31 Vinod 13 M 498456 + - - - - - 
+ 
(IOF
B) 
- + - V 
+ 
(IOF
B) 
- SH ASP HM CFCF 3 - 
32 Radhammal 38 F 498713 + - - - - - 
+ 
(IOF
B) 
- + - IV 
+ 
(IOF
B) 
- - - PL+ PL+ 2 + 
33 Kannama 29 F 500201 + - - - - - + - - - IV + - - - NO PL 
NO 
PL 
2 - 
34 Dasharathan 34 M 500632 + - - - - - + - - - IV + - - - NO PL 
NO 
PL 
1 - 
35 Chandran 42 M 495433 + - - - - - + - - - V + GPC - S.AUR PL+ HM 2 + 
36 Paappa 26 M 492324 + - - - - - + - - - IV + GPC - S.EPI HM 1/60 2 - 
37 Thulukkaanam 45 M 498865 + - - - - - - + - - V + - SH ASP PL+ PL+ 2 - 
38 Vasuki 55 F 492764 + - - - - - + - - - IV + - - - NO PL 
NO 
PL 
1 - 
39 Gayathri 13 F 498335 + - - - - - + - - - IV + - - - PL+ 6/60 2 + 
40 Vembelu 37 F 492873 + - - - - - + - + - III + - - - 1/60 6/36 2 - 
41 Subramani 49 M 493219 - - + - - - + - - - IV + - - - NO PL 
NO 
PL 
1 - 
  
 
SL. 
No. 
Name 
A
ge 
Se
x 
IP NO. 
Onset Asst. Illness Type 
HYPOP
YON 
Vitreous 
Loss 
IDO
vitrit
is 
B 
Scan 
Gm 
Stain 
VIT 
KOH 
Stain 
VIT 
Culture 
VIT 
Visual Acuity INT
RA
VIT
RE
AL 
CV 
A/C IM D DM FS END PT PostOp Initial Final 
42 Paraman 58 M 498280 + - - - - - + - - - IV + GPC - S.EPI HM 2/60 2 - 
43 Panchalai 32 F 493234 - + - - - - + - - - IV + - - - NO PL 
NO 
PL 
3 - 
44 Jayavel 20 M 493862 - + - - - - + - + - IV + - - - HM 2/60 2 - 
45 Vimal 24 M 497657 - + - - - - + - + - V + - SH ASP NO PL 
NO 
PL 
2 - 
46 Pakirappan 62 M 497658 - + - + + - + - - - V + - - - NO PL 
NO 
PL 
1 - 
47 Mumtaz 29 F 429264 + - - - - - + - - - IV + GPC - S.AUR PL+ HM 2 + 
48 Raman 68 M 497660 - - + + - - - - + - IV + - - - HM CFCF 2 - 
49 Anjalai 61 F 21582 - - + + - - - - + - IV + GNB - 
Pseudo 
monas 
NO PL EVIS 2 - 
50 Anbarasu 4 M 58622 - - + - - - - - + - V + - - - PL+ PL+ 2 - 
 
 
 
 
 
 
 
  
 
ABBREVATIONS 
 
A/C Acute 
IN Insidious 
D Delayed 
DM Diabetes Mellitus 
FS Focal Sepsis 
AC  Anterior Chamber 
PC Posterior Chamber 
PT  Post traumatic 
Post op Post-operative 
IDO Indirect Ophthalmoscopy 
VIT Vitreous tap 
V/A Visual acuity 
PL Perception of light 
PR Projection of rays 
HM Hand movements 
CFCF Counting fingers close to face 
SH Septate hyphae 
GPC Gram positive cocci 
GPB Gram positive cocci 
GNB Gram negative bacilli 
AG Anti-glaucoma  
RD Retinal detachment 
K Keratoplasty 
ECCE Extra Capsular Cataract Extraction 
SICS Small Incision Cataract Surgery 
PHACO Phacoemulsification 
IOL Intraocular lens 
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